New retrofit SPECT system

Existing preclinical CT platforms now can be retrofitted with a scaled-down SPECT system, announced Winnipeg, Manitoba, Canada, molecular imaging company Cubresa April 16.

The first system will be added to Biomedical Translational Imaging Centre (BIOTIC) of the Izaak Walton Killman (IWK) Health Centre, a pediatric and women’s hospital in Halifax, Nova Scotia.

“Cubresa’s attachable SPECT allows us to perform research, along with our clinical partners, that will advance the development of next-generation clinical diagnostics for a variety of diseases including epilepsy, Alzheimer’s and others,” said Steven D. Beyea, lead scientist IWK’s BIOTIC, via press release. “Such innovations in the early diagnosis of diseases are critical to improved healthcare delivery.”

The primary function of these newly hybrid molecular systems is to quicken translational research and new drug trials. They have a slim bore and close-to-contact detectors.

“We are designing products to work with a variety of small animal CT scanners, providing customers with a lot of flexibility in upgrading their equipment,” added James Schellenberg, founder and CEO of Cubresa, first incorporated in 2011.

 

Around the web

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.